BNC Share Price

Open 22.32 Change Price %
High 22.32 1 Day 0.00 0.00
Low 22.32 1 Week 0.00 0.00
Close 22.32 1 Month 0.03 0.13
Volume 100 1 Year 22.11 10528.57
52 Week High 22.32
52 Week Low 20.15
BNC Important Levels
Resistance 2 22.32
Resistance 1 22.32
Pivot 22.32
Support 1 22.32
Support 2 22.32
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
BIN 41.40 -1.62%
LSG 2.08 8.33%
LSG 2.08 8.33%
LSG 2.08 8.33%
TBE 0.03 0.00%
SC 60.83 -0.44%
PRE 0.64 0.00%
PRE 0.64 0.00%
PRE 0.64 0.00%
More..
TSE Canada Top Gainers Stocks
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
TVI 0.02 100.00%
CUM 0.90 13.92%
CUM 0.90 13.92%
GVC 0.81 10.96%
GVC 0.81 10.96%
LSG 2.08 8.33%
LSG 2.08 8.33%
More..
TSE Canada Top Losers Stocks
GBV 0.46 -24.59%
CTU-A 0.19 -9.52%
QEC 0.80 -8.05%
QEC 0.80 -8.05%
SJ 39.41 -7.68%
LUN 7.65 -7.50%
LUN 7.65 -7.50%
TBL 1.01 -7.34%
ORT 0.26 -7.14%
ORT 0.26 -7.14%
More..

Bioniche Life Sciences Inc (TSE: BNC)

BNC Technical Analysis 5
As on 6th Jan 2017 BNC Share Price closed @ 22.32 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.05 & Strong Buy for SHORT-TERM with Stoploss of 3.66 we also expect STOCK to react on Following IMPORTANT LEVELS.
BNC Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
BNC Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.bioniche.com
BNC Address
BNC
231 Dundas Street East
Belleville, ON K8N 1E2
Canada
Phone: 613-966-8058
Fax: 613-966-4177
Interactive Technical Analysis Chart Bioniche Life Sciences Inc ( BNC TSE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Bioniche Life Sciences Inc
BNC Business Profile
Bioniche Life Sciences Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, manufacture, and marketing of proprietary products for the human health markets. Its lead product, Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) suspension, is a complex biologic immunotherapy/immunomodulator designed for the treatment of non-muscle-invasive bladder cancer in humans, which is in Phase III clinical development. The company was formerly known as Vetrepharm Animal Health Inc. Bioniche Life Sciences Inc. was founded in 1979 and is headquartered in Belleville, Canada.